Mechanism of radiosensitization by porphyrins

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 25, Issue 1-2, 2006, Pages 293-306

  Lukšiene, Živile ^a   Labeikyte, Danute ^a   Juodka, Benediktas ^a   Moan, Johan ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Mechanism; Porphyrins; Radiosensitization

Indexed keywords

BENZODIAZEPINE RECEPTOR; GLUTATHIONE TRANSFERASE; HEMATOPORPHYRIN DIMETHYL ETHER; PORPHYRIN DERIVATIVE; RADIOSENSITIZING AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER THERAPY; CELL COUNT; CELL CYCLE; CELL CYCLE S PHASE; CONTROLLED STUDY; EHRLICH ASCITES TUMOR CELL; ENZYME ACTIVITY; GAMMA IRRADIATION; IONIZING RADIATION; MITOSIS; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIOSENSITIZATION;

ANIMALIA;

EID: 33644785033     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.190     Document Type: Article

References (33)

1. Jori G. Tumor photosensitizers: approaches to enhance the efficiency and selectivity of photodynamic therapy. J Photochem Photobiol B 1996; 36(2):87-93.
2. Byrne CJ, Marchallsay LV, Ward AD. The chemical composition of Photofrin. J Photochem Photobiol B 1990; 6(1-2):13-7.
3. Schaffer M, Ertl-Wagner B, Schaffer PM, Kulka U, Hofstetter A, Duhmke E, Jori G. Porphyrins as radiosensitizing agents for solid neoplasms. Curr Pharm Des. 2003; 9(25):2024-35.
4. Pogue BW, O'Hara JA, Demidenko E, Wilmot CM, Goodwin IA, Chen B, Swartz HM, Hasan T. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. Cancer Res 2003; 63(5):1025-33.
5. Bellnier DA, Ho YK, Pandey RK, Missert JR, Dougherty TJ. Distribution and elimination of photofrin II in mice. Photochem Photobiol 1989; 50(2):221-28.
6. Orenstein A, Kostenich G, Roitman L, Shechtman Y, Kopolovic Y, Ehrenberg B, Malik Z. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e-6, Photofrin II and ALA-induced protoporphyrin IX in a carcinoma model. Br J Cancer 1996; 73(8):937-44.
7. Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 1993; 85(6):443-56.
8. Cohen L, Schwartz S. Modification of radiosensitivity by porphyrins: II Transplanted myosarcoma in mice. Cancer Res 1966; 26(8):1769-73.
9. Schwartz S, Absolon K, Vermund H. Some relationships of porphyrins, X-rays, and tumours. Univ Minn Med Bull 1955; 27:1-37.
10. Schwartz S, Keprios M, Modelevsky G, Freyholtz H, Walters R, Larson L. Modification of radiosensitivity by porphyrins, studies of tumours and other systems. In: Doss M, editor. Diagnosis and Therapy of Porphyrias and Lead Intoxication. Berlin: Springer-Verlag, 1978; 227-237.
11. Moan J, Petersen EO. X-irradiation of human cells in culture in the presence of haematoporphyrin. Int J Radiat Biol Relat Stud Phys Chem Med 1981; 40(1):107-9.
12. Zhao FY, Zhang KH, Huang HN, Sun KN, Ling QB, Xu B. Use of haematoporphyrin derivative as a sensitizer for radiotherapy of oral and maxillofacial tumours: a preliminary report. Lasers in Med Sci 1986; 1:253-256.
13. Kostron H, Swartz MR, Miller DC, Martuza RL. The interaction of hematoporphyrin derivate, light, and ionizing radiation in a rat glioma model. Cancer 1986; 57(5):964-70.
14. Chen DY. The use of hematoporphyrin derivative (HpD) as a sensitizer to radiation therapy in treatment of S 180 mice. Treat Laser 1985; 5:137.
15. 60Co irradiated cells of different nature. Proc SPIE 1993; 2078:447-52.
16. 60Co irradiation with PDT. Proc SPIE 1993; 1881:67-75.
17. Luksiene Z, Kalvelyte A, Supino R. On the combination of photodynamic therapy and ionising radiation. J Photochem Photobiol B 1999; 52(1-3):35-42.
18. Kulka U, Schaffer M, Siefert A, Schaffer PM, Olsner A, Kasseb K, Hofstetter A, Duhmke E, Jori G. Photofrin as a radiosensitizer in an in vitro cell survival assay. Biochem Biophys Res Commun 2003; 311(1):98-103.
19. 4 in two different types of mice tumors. Acta Medica Lithuanica 2002; 9(1):62-6.
20. Luksiene Z, Kaspariunaite G, Pasukoniene V, Characiejus D. Relationship between transplanted Ehrlich ascite tumor growth in BALB/C mice and its cytogenetic and cytokinetic characteristics. Acta Medica Lithuanica 1996; 2(1):34-8.
21. Ferlini C, Cesare S, Rainaldi S, Halorni W, Samoggia P, Biselli R, Fattorossi A. Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry 1996; 24(2):106-15.
22. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem 1976; 72:249-54.
23. Nias AHW. An introduction to radiobiology. New York: Wiley, 1998.
24. Luksiene Z. Experimental evidence on possibility to radiosensitize aggressive tumors by porphyrins. Medicina (Kaunas) 2004; 40(9):868-74.
25. Schaffer M, Schaffer PM, Corti L, Gardiman M, Sotti G, Hofstetter A, Jori G, Duhmke E. Photofrin II as an efficient radiosensitizing agent in an experimental tumor. Oncologie 2001; 24(5):482-5.
26. Schaffer M, Schaffer PM, Corti L, Gardiman M, Sotti G, Hofstetter A, Jori G, Duhmke E. Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model. J Photochem Photobiol 2002; 66(3):57-64.
27. Schaffer M, Schaffer PM, Hofstetter A, Duhmke E, Jori G. On the double role of Photofrin as a photo- and radio-sensitizing agent: a possible new combination therapy for tumors. Photochem Photobiol Sci 2002; 1:438-39.
28. Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 1999; 51(4):629-50.
29. Li Y, Jaiswal AK. Regulation of human NAD (P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. J Biol Chem 1992; 267(21):15097-104.
30. Maaser K, Hopfner M, Jansen A, Weisinger G, Gavish M, Kozikowski AP, Weizman A, Carayon P, Riecken EO, Zeitz M, Scherubl H. Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells. Br J Cancer 2001; 85(11):1771-80.
31. Krivickiene Z, Urbanaviciute V, Tamosiunas, Luksiene Z. The effect of hematoporphyrin dimethyl ether on the protein level of Cyclin D3 and Cyclin dependent kinase inhibitor p27Kip1 in Ehrlich ascite tumor cells. Acta Medica Lithuanica 2003; 10(1):16-19.
32. Carmel I, Fares FA, Leschiner S, Scherubl H, Weisinger G, Gavish M. Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line. Biochem Pharmacol 1999; 58(2):273-8.
33. Landau M, Weizman A, Zoref-Shani E, Beery E, Wasseman L, Landau O, Gavish M, Brenner S, Nordenberg J. Antiproliferative and differentiating effects of benzodiazepine receptor ligands in B16 melanoma cells. Biochem Pharmacol 1998; 56(8):1029-34.